IP Library Granted Patent US 10,772,930
Granted Patent B2
US 10,772,930 · App. 15/937,416 · Granted Sep 15, 2020

Use of a bacterium isolated from the genus

Inventors: Florie Desriac (Bannalec, FR); Yannick Fleury (Quimper, FR); Patrick Le Chevalier (Clohars-Fouesnant, FR); Delphine Destoumieux (Viols-le-Fort, FR); Matthieu Simon (Rennes, FR)
Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.); UNIVERSITE DE RENNES 1; UNIVERSITE DE BRETAGNE OCCIDENTALE
A61K38/12A23K10/18A23K20/195A23K50/80A61K35/74A61K35/741C07K7/56C07K7/64C11D3/28C11D3/32C11D3/381C11D3/48C12R1/01A61K38/00A61K2035/11Y02A40/818
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,772,930
App. No.
15/937,416
Granted
Sep 15, 2020
Kind
B2
Abstract

The present invention relates to an isolated bacterium from the genus Pseudoalteromonas for its use as a probiotic, the use of said strain as a preservative, cyclolipopeptides which may be obtained from this bacterium, a composition comprising at least such a cyclolipopeptide, as well as to their uses.

Claims (18)

1. An anti-bacterial composition comprising (a) a therapeutically effective amount of the cyclolipoprotein of formula A:

wherein R is selected from the group consisting of:

(i) alkyl groups comprising between 4 and 20 carbon atoms, except nonyl and undecyl groups;

(ii) alkylene groups comprising between 4 and 20 carbon atoms, except undec-4-ylene and tridec-6-ylene groups;

(iii) alkyl groups substituted with an —OH group and comprising between 4 and 20 carbon atoms; and

(iv) alkylene groups substituted with an —OH group and comprising between 4 and 20 carbon atoms, and (b) an effective amount of an adjuvant.

2. The composition according to claim 1 , wherein R is selected from the group consisting of:

(i) alkyl groups comprising between 6 and 14 carbon atoms, except nonyl and undecyl groups;

(ii) alkylene groups comprising between 6 and 14 carbon atoms, except undec-4-ylene and tridec-6-ylene groups;

(iii) alkyl groups substituted with an —OH group and comprising between 6 and 14 carbon atoms; and

(iv) alkylene groups substituted with an —OH group and comprising between 6 and 14 carbon atoms.

3. The composition according to claim 2 , wherein R is selected from the group consisting of the groups: nonylene, nonanol, heptyl, octylene, octyl, decyldiene, decanyl, decanol, decylene, octenol, dodecylene and tridecyltriene.

4. The composition according to claim 1 , wherein the cyclolipoprotein is obtained from a bacterium.

5. The composition according to claim 1 , wherein the composition is a pharmaceutical composition.

6. The composition according to claim 3 , wherein R is nonyl-2-ene.

7. The composition according to claim 3 , wherein R is nonan-2-ol.

8. The composition according to claim 1 , further comprising an organic solvent.

9. The composition according to claim 8 , wherein the organic solvent is glycerol or a glycol, or a mixture of glycerol and the glycol.

Assignments (2)
MERGER Recorded Oct 19, 2023
From: UNIVERSITE DE RENNES I
To: UNIVERSITE DE RENNES
Reel/Frame 065490/0667 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 24, 2019
From: DESRIAC, FLORIE; FLEURY, YANNICK; LE CHEVALIER, PATRICK; DESTOUMIEUX, DELPHINE; SIMON, MATTHIEU
To: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.); UNIVERSITE DE RENNES 1; UNIVERSITE DE BRETAGNE OCCIDENTALE
Reel/Frame 049278/0682 →